Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Microsystems & Nanoengineering|September 27, 2021
Continuous roll-to-roll patterning of three-dimensional periodic nanostructuresI-Te Chen, Elizabeth Schappell, Xiaolong Zhang, et al.
Clinical Pediatrics|August 9, 2002
Comparison of temple temperatures with rectal temperatures in children under two years of ageGeorge K Siberry, Marie Diener-West, Elizabeth Schappell, et al.
The Journal of Infectious Diseases|March 14, 2013
Attenuation of live respiratory syncytial virus vaccines is associated with reductions in levels of nasal cytokinesRuth A Karron, Bhagvanji Thumar, Elizabeth Schappell, et al.
Vaccine|December 20, 2011
Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young childrenRuth A Karron, Bhagvanji Thumar, Elizabeth Schappell, et al.
The Journal of Infectious Diseases|February 13, 2009
A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adultsRuth A Karron, Karen Callahan, Catherine Luke, et al.
JAMA Network Open|August 31, 2022
Assessment of Clinical and Virological Characteristics of SARS-CoV-2 Infection Among Children Aged 0 to 4 Years and Their Household MembersRuth A Karron, Marissa K Hetrich, Yu Bin Na, et al.
Vaccine|June 23, 2009
Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adultsRuth A Karron, Kawsar Talaat, Catherine Luke, et al.
Vaccine|October 10, 2013
Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young childrenJanet A Englund, Ruth A Karron, Coleen K Cunningham, et al.
Open Forum Infectious Diseases|June 19, 2019
Live-Attenuated Respiratory Syncytial Virus Vaccine With Deletion of RNA Synthesis Regulatory Protein M2-2 and Cold Passage Mutations Is OverattenuatedColeen K Cunningham, Ruth Karron, Petronella Muresan, et al.
The Journal of Infectious Diseases|March 7, 2018
Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and ChildrenUrsula J Buchholz, Coleen K Cunningham, Petronella Muresan, et al.
Pageof 2